FIRST MIDWEST BANK TRUST DIVISION - INTELLIPHARMACEUTICS INTL IN ownership

INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 22 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q3 2014. The put-call ratio across all filers is 28.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
FIRST MIDWEST BANK TRUST DIVISION ownership history of INTELLIPHARMACEUTICS INTL IN
ValueSharesWeighting
Q3 2015$29,000
-79.1%
16,120
-65.8%
0.01%
-77.3%
Q2 2015$139,000
+5.3%
47,1520.0%0.02%
+10.0%
Q1 2015$132,000
+25.7%
47,152
+1.0%
0.02%
+25.0%
Q4 2014$105,000
-29.5%
46,672
-5.5%
0.02%
-33.3%
Q3 2014$149,000
-19.0%
49,372
+2.1%
0.02%
-17.2%
Q2 2014$184,000
-10.2%
48,342
+3.5%
0.03%
-12.1%
Q1 2014$205,00046,6920.03%
Other shareholders
INTELLIPHARMACEUTICS INTL IN shareholders Q3 2014
NameSharesValueWeighting ↓
FIRST FOUNDATION ADVISORS 50,000$90,0000.01%
FIRST MIDWEST BANK TRUST DIVISION 16,120$29,0000.01%
Nine Chapters Capital Management LLC 12,900$23,0000.00%
BANK OF AMERICA CORP /DE/ 6$00.00%
WELLS FARGO & COMPANY/MN 1,027$2,0000.00%
GROUP ONE TRADING, L.P. 12,109$22,0000.00%
1832 Asset Management L.P. 10,012$18,0000.00%
TORONTO DOMINION BANK 34$00.00%
DEUTSCHE BANK AG\ 117,727$213,0000.00%
MORGAN STANLEY 59,700$109,0000.00%
View complete list of INTELLIPHARMACEUTICS INTL IN shareholders